MedWatch

Merck Ventures invests in Novo Seeds company

A British biotech company, which develops next generation immunotherapies and counts Novo Seeds among its owners, has been given a sizeable sum from Germany’s Merck Ventures.

Partner i Novo Seeds

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Omstridt parallelimportør går konkurs

Parallelimportøren Europharma, der to gange i 2017 blev suspenderet af Lægemiddelstyrelsen, er gået konkurs. Selskabet har erkendt, at et varelager for 50 mio. kr. er usælgeligt.

Related articles